Intraseptal implantation of NGF-releasing microspheres promote the survival of axotomized cholinergic neurons

Biomaterials

Volumn 21, Issue 20, 2000, Pages 2097-2101

  Péan, Jean Manuel ^a   Menei, Philippe ^a,b   Morel, Olivier ^a   Montero Menei, Claudia N ^a   Benoit, Jean Pierre ^a  

^a UNIVERSITÉ D'ANGERS   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

Cholinergic neuron; Drug delivery; Eurotrophic factor; Microsphere; Nerve growth factor; Neuroprotection

Indexed keywords

BIODEGRADATION; CONTROLLED DRUG DELIVERY; COPOLYMERS; PARTICLES (PARTICULATE MATTER); POLYESTERS; TOXICITY;

MICROSPHERES; POLYGLYCOLIDE; POLYLACTIDE;

IMPLANTS (SURGICAL);

MICROSPHERE; NERVE GROWTH FACTOR; POLYGLACTIN;

ANIMAL MODEL; ARTICLE; CELL SURVIVAL; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; DRUG SAFETY; FOREBRAIN; HISTOLOGY; NERVE FIBER TRANSECTION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; AXOTOMY; DRUG IMPLANTS; FEMALE; MICROSPHERES; NASAL SEPTUM; NERVE GROWTH FACTOR; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CHOLINERGIC;

ANIMALIA;

EID: 0343496889     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(00)00141-1     Document Type: Article

References (26)

1. Hefti F. Neurotrophic factor therapy-keeping score. Nat Med. 3(5):1997;497-498.
2. Menei P., Benoit J.P., Boisdron-celle M., Fournier D., Mercier P., Guy G. Drug targeting into the central nervous system by stereotactic implantation of biodegradable microspheres. Neurosurgery. 34:1994;1058-1064.
3. Menei P., Venier M.C., Gamelin E., Saint-André J.P., Hayek G., Jadaud E., Fournier D., Mercier P., Guy G., Benoit J.P. Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for radiosensitisation of glioblastoma. pilot study Cancer. 86(2):1999;325-330.
4. Camarata P.J., Suryanarayanan R., Turner D.A., Parker R.G., Ebner T.J. Sustained release of nerve growth factor from biodegradable polymer microspheres. Neurosurgery. 30(3):1992;313-319.
5. Krewson C.E., Dause R., Mak M., Saltzman W.M. Stabilization of nerve growth factor in controlled release polymers and in tissue. J Biomater Sci Polym Ed. 8(2):1996;103-117.
6. Maysinger D., Filipovic-Grcic, Cuello C. Effects of coencapsulated NGF and GM1 in rats with cortical lesions. Neuroreports. 4:1993;971-974.
7. Krewson C.E., Klarman M.L., Saltzman W.M. Distribution of nerve growth factor following direct delivery to brain interstitium. Brain Res. 680:1995;196-206.
8. Saltzman W.M., Mak W.M., Mahoney M.J., Duenas E.T., Cjeland J.L. Intracranial delivery of recombinant nerve growth factor. release kinetics and protein distribution for three delivery systems Pharm Res. 16:1999;231-240.
9. Mahoney M.J., Saltzman W.M. Millimeter-scale positioning of a nerve-growth-factor source and biological activity in the brain. Proc Natl Acad Sci USA. 96:1999;4536-4539.
10. Péan J.M., Venier-Julienne M.C., Filmon R., Sergent M., Phan-Tan-Luu R., Benoit J.P. Optimization of HSA and NGF encapsulation yields in PLGA microparticles. Int J Pharm. 166:1998;105-115.
11. Péan J.M., Venier-Julienne M.C., Boury F., Menei P., Denizot B., Benoit J.P. NGF release from poly(D,L-lactide-co-glycolide) microsphere. Effect of some formulation parameters on encapsulated NGF stability. J Control Rel. 56:1998;175-187.
12. Péan JM, Boury F, Venier-Julienne MC, Proust JE, Benoit JP. Why does PEG 400 co-encapsulation improve NGF stability and release from PLGA biodegradable microspheres? Pharm Res 1999;16(8)1999;1294-9.
13. Hefti F. Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J Neurosci. 6(8):1986;2155-2162.
14. Montero C.N., Hefti F. Rescue of lesioned septal cholinergic neurons by nerve growth factor. specificity and requirement for chronic treatment J Neurosci. 8(8):1988;2986-2999.
15. Montero-Menei C.N., Pouplard-Barthelaix A., Gumpel M., van Evercooren B. Pure schwann cell suspension grafts promote regeneration of the lesioned septo-hippocampal cholinergic pathway. Brain Res. 570:1992;198-208.
16. Menei P., Daniel V., Montero-Menei C., Brouillard M., Pouplard-Barthelaix A., Benoit J.P. Biodegradation and brain tissue reaction to poly(D,L-lactide-co-glycolide) microspheres. Biomaterials. 14(6):1993;470-478.
17. Eckenstein F., Sofroniew M.W. Identification of central cholinergic neurons containing both choline acetyltransferase and acetyl-cholinesterase and of central neurons containing only acetyl-cholinesterase. J Neurosci. 3:1983;2286-2291.
18. Naumann T., Straube A., Frotscher M. Recovery of ChAT immunoreactivity in axotomized rat cholinergic septal neurons despite reduced NGF receptor expression. Eur J Neurosci. 9(7):1997;1340-1349.
19. Junard E.O., Montero C.N., Hefti F. Long term administration of mouse nerve growth factor to adult rats with partial lesions of the cholinergic septohippocampal pathway. Exp Neurol. 110:1990;25-38.
20. Williams L.R. Hypophagia is induced by intracerebroventricular administration of nerve growth factor. Exp Neurol. 113:1991;31-37.
21. Hu L., Cote S.L., Cuello C. Differential modulation of the cholinergic phenotype of the nucleus basalis magnocellularis neurons by applying NGF at the cell body of cortical terminal fields. Exp Neurol. 143:1997;162-171.
22. Hemerich D.F., Tracy M.A., Ward K.L.et al. Biocompatibility of poly(DL-lactide-co-glycolide) microspheres implanted into the brain. Cell Transplantation. 8:1999;47-58.
23. Kou J.H., Emmett C., Shen P., Aswani S., Iwamoto T., Vaghefi F., Cain G., Sanders L. Bioerosion and biocompatibility of poly(D,L-lactic-co-glycolic acid) implants in brain. J Control Rel. 43:1997;123-130.
24. Martinez-Serrano A., Lundberg C., Horellou P., Fisher W., Bentlage C., Campbell K., Mckay R.D.G., Mallet J., Bjorklund A. CNS-derived neural progenitor cells for gene transfer of nerve growth factor to the adult rat brain. complete rescue of axotomized cholinergic neurons after transplantation into the septum J Neurosci. 15(8):1995;5668-5680.
25. Nanduri J., Vroegop S.M., Buxser S.E., Neet K.E. Immunological determinants of nerve growth factor involved in p140 trk (Trk) receptor binding. J Neurosci Res. 37(4):1994;433-444.
26. Menei P., Boisdron-celle M., Croué A., Guy G., Benoit J.P. Effect of stereotactic implantation of biodegradable 5-fluorouracil-loaded microspheres in healthy and C6 glioma-bearing rats. Neurosurgery. 39:1996;117-124.